In colorectal cancer, the β-catenin-TCF signaling pathway was reported to regulate FSCN1 transcription [84]; however, the studies in breast and colon cancer failed to report the regulation of FSCN1 expression via β-catenin-TCF signaling [77,85]. This evidence concerns the gene HNF4A and colonic neoplasm.